The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Abstract
Fibroblast growth factor 21 (FGF21) is a metabolic regulator that provides efficient and durable glycemic and lipid control in various animal models. However, its potential to treat obesity, a major health concern affecting over 30% of the population, has not been fully explored. Here we report that systemic administration of FGF21 for 2 wk in diet-induced obese and ob/ob mice lowered their mean body weight by 20% predominantly via a reduction in adiposity. Although no decrease in total caloric intake or effect on physical activity was observed, FGF21-treated animals exhibited increased energy expenditure, fat utilization, and lipid excretion, reduced hepatosteatosis, and ameliorated glycemia. Transcriptional and blood cytokine profiling studies revealed effects consistent with the ability of FGF21 to ameliorate insulin and leptin resistance, enhance fat oxidation and suppress de novo lipogenesis in liver as well as to activate futile cycling in adipose. Overall, these data suggest that FGF21 exhibits the therapeutic characteristics necessary for an effective treatment of obesity and fatty liver disease and provides novel insights into the metabolic determinants of these activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prolonged administration of FGF21 or FGF21 analogues has important metabolic effects, including a marked decrease in body weight in rodents and non-human primates, and more modest effects on body weight in humans3,40,58,77,78.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [77]
In the citing paper
“Pharmacological administration of FGF21 to obese rodents reverses diabetes and obesity through increasing energy expenditure77,78.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [77]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“A myriad of studies ensued demonstrating that administering FGF21 to obese or diabetic rodents and primates markedly reduced body weight and significantly improved carbohydrate and lipid homeostasis (21, 64, 65, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“When administered to diabetic and obese animal models, FGF21 provides multiple metabolic benefits and has been shown to decrease blood glucose levels and body weight, improve insulin and leptin sensitivity, improve plasma lipid profiles, and decrease hepatic steatosis (21, 64, 141, 142).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“Importantly, in animal models FGF21 treatment not only prevents (64) but also reverses diabetes and obesity (21, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“Since FGF21 administration increases energy expenditure and the browning of adipose tissues in vivo (21, 64, 141), it was hypothesized that FGF21 regulates adaptive thermogenesis in response to cold.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“It is clear that FGF21 treatment elicits significant metabolic changes in many tissues, including the liver and adipose tissues (21, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“FGF21’s ability to reduce body weight, glucose levels, and lipid concentrations in models of obesity generated substantial initial interest”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [116]
Citations
Cites
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Self-citationCellular signaling by fibroblast growth factor receptors
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,923
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123
Handschin, C., & Spiegelman, B. M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0037 · Cited by 1,090
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,012
Self-citationIdentification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
Cohen, P., Miyazaki, M., Socci, N. D., Hagge-Greenberg, A., Liedtke, W., Soukas, A. A., Sharma, R., Hudgins, L. C., Ntambi, J. M., & Friedman, J. M. (2002) · Science · doi:10.1126/science.1071527 · Cited by 826
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 995
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 57
Vienberg, S. G., Brøns, C., Nilsson, E., Astrup, A., Vaag, A., & Andersen, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0039 · Cited by 47
Zhang, X., Lv, S., Luo, Z., Hu, Y., Peng, X., Lv, J., Zhao, S., Feng, J., Huang, G., Wan, Q.-L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab174 · Cited by 46
Jani, S., Eira, D. D., Stefanovic, M., & Ceddia, R. B. (2022) · The Journal of Physiology · doi:10.1113/jp283552 · Cited by 53
Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet
Gao, M., Ma, Y., Cui, R., & Liu, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.047 · Cited by 48
Yang, C., Wang, C., Ye, M., Jin, C., He, W., Wang, F., McKeehan, W. L., & Luo, Y. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-94 · Cited by 48
Hepatic hormone FGF21 and its analogues in clinical trials
Shao, W., & Jin, T. (2021) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2021.08.005 · Cited by 49
Beenken, A., Eliseenkova, A. V., Ibrahimi, O. A., Olsen, S. K., & Mohammadi, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275891 · Cited by 48
Le, T. D. V., Fathi, P. A., Watters, A. B., Ellis, B. J., Besing, G.-L. K., Bozadjieva-Kramer, N., Perez, M. B., Sullivan, A. I., Rose, J. P., Baggio, L. L., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101718 · Cited by 49
Physical exercise in kidney disease: A commonly undervalued treatment modality
Kanbay, M., Çöpür, S., Yıldız, A. B., Tanrıöver, C., Mallamaci, F., & Zoccali, C. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14105 · Cited by 49
MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet
Gadang, V., Kohli, R., Myronovych, A., Hui, D. Y., Pérez–Tilve, D., & Jaeschke, A. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00197.2013 · Cited by 46
Loyd, C., Magrisso, I. J., Haas, M., Balusu, S., Krishna, R., Itoh, N., Sandoval, D. A., Pérez–Tilve, D., Obici, S., & Habegger, K. M. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00456.2016 · Cited by 49
Santoso, P., Nakata, M., Shiizaki, K., Boyang, Z., Parmila, K., Otgon-Uul, Z., Hashimoto, K., Satoh, T., Mori, M., Kuro‐o, M., et al. (2017) · Scientific Reports · doi:10.1038/srep45819 · Cited by 45
Heparin‐poloxamer hydrogel‐encapsulated rhFGF21 enhances wound healing in diabetic mice
Liu, H., Zhao, Y., Zou, Y., Huang, W., Zhu, L., Liu, F., Wang, D., Guo, K., HU, J. L., Chen, J., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802600rr · Cited by 46
Role of hepatokines in non-alcoholic fatty liver disease
Ke, Y., Xu, C., Lin, J., & Li, Y. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0029 · Cited by 46
Old Paradoxes and New Opportunities for Appetite Control in Obesity
Montégut, L., López-Otín, C., Magnan, C., & Kroemer, G. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.005 · Cited by 48
Metabolic actions of fibroblast growth factor 21
Ramos, D. C., Aguilar-Salinas, C. A., & Gomez-Perez, F. J. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283557d22 · Cited by 46
Castro, É., Silva, T. E. O., & Festuccia, W. T. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0042 · Cited by 48
Stemmer, K., Zani, F., Habegger, K. M., Neff, C., Kotzbeck, P., Bauer, M., Yalamanchilli, S., Azad, A., Lehti, M., Martins, P. J. F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3668-7 · Cited by 44
Kim, E. R., Kim, S. R., Cho, W., Lee, S., Kim, S. H., Kim, J. H., Choi, E., Kim, J., Yu, J., Lee, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843520 · Cited by 44
Toward reconciling the roles of FGF21 in protein appetite, sweet preference, and energy expenditure
Solon‐Biet, S. M., Clark, X., Bell-Anderson, K. S., Rusu, P. M., Perks, R., Freire, T., Pulpitel, T., Senior, A. M., Hoy, A. J., Aung, O., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113536 · Cited by 43
Maletı́nská, L., Matyšková, R., Maixnerová, J., Sýkora, D., Pýchová, M., Špolcová, A., Blechová, M., Drápalová, J., Lacinová, Z., Haluzı́k, M., et al. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.006 · Cited by 46
Ge, H., Baribault, H., Vonderfecht, S. L., Lemon, B. D., Weiszmann, J., Gardner, J., Lee, K. J., Gupte, J., Mookherjee, P., Wang, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033603 · Cited by 43
Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21
Camporez, J. P., Asrih, M., Zhang, D., Kahn, M., Samuel, V. T., Jurczak, M. J., & Jornayvaz, F. R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0136 · Cited by 44
Breher-Esch, S., Sahini, N., Trincone, A., Wallstab, C., & Borlak, J. T. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0438-7 · Cited by 42
Gao, R.-Y., Hsu, B., Wu, D.-A., Hou, J.-S., & Chen, M.-C. (2019) · International Journal of Endocrinology · doi:10.1155/2019/5163245 · Cited by 46
Watanabe, M., Singhal, G., Fisher, F. M., Beck, T. C., Morgan, D. A., Socciarelli, F., Mather, M. L., Risi, R., Bourke, J., Rahmouni, K., et al. (2019) · Endocrine · doi:10.1007/s12020-019-02124-3 · Cited by 44
Gao, J., Liu, J., Meng, Z., Li, Y., Hong, Y., Wang, L., He, L., Hu, B. Q., Zheng, Y., Li, T., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.015 · Cited by 44
Breaking BAT: can browning create a better white?
Warner, A., & Mittag, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0408 · Cited by 45
Liu, M., Pan, Q., Chen, Y., Yang, X., Zhao, B., Jia, L., Zhu, Y., Zhang, B., Gao, X., Li, X., et al. (2015) · Scientific Reports · doi:10.1038/srep11219 · Cited by 45
Self-citationFibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease
Kralisch, S., & Faßhauer, M. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328346a326 · Cited by 44
Xu, X., Krumm, C. S., So, J., Bare, C. J., Holman, C. D., Gromada, J., Cohen, D. E., & Lee, A. (2018) · Hepatology · doi:10.1002/hep.30060 · Cited by 43
The influence of skeletal muscle on appetite regulation
Grannell, A., VITO, G. D., Murphy, J. C., & le Roux, C. W. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1618185 · Cited by 46
YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity
Wang, L., Mazagova, M., Pan, C., Yang, S. T., Brandl, K., Liu, J., Reilly, S. M., Wang, Y., Miao, Z., Loomba, R. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904360116 · Cited by 43
Forney, L. A., Fang, H., Sims, L. C., Stone, K. P., Vincik, L. Y., Vick, A. M., Gibson, A. N., Burk, D. H., & Gettys, T. W. (2020) · Obesity · doi:10.1002/oby.22919 · Cited by 43
Serum fibroblast growth factor 21 levels in polycystic ovary syndrome
Görar, S., Çulha, C., Üç, Z. A., Dellal, F. D., Serter, R., Aral, S., & Aral, Y. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487587 · Cited by 43
Molecular Mechanisms of Exercise and Healthspan
Guan, Y., & Yan, Z. (2022) · Cells · doi:10.3390/cells11050872 · Cited by 48
Zhang, J., & Li, Y. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.007 · Cited by 44
Sahini, N., & Borlak, J. (2016) · Translational Research: The Journal of Laboratory and Clinical Medicine · doi:10.1016/j.trsl.2016.06.003 · Cited by 47
Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency
Zarei, M., Barroso, E., Leiva, R., Barniol‐Xicota, M., Pujol, E., Escolano, C., Vázquez, S., Palomer, X., Pardo, V., González‐Rodríguez, Á., et al. (2016) · Diabetes · doi:10.2337/db16-0155 · Cited by 42
Curcumin and dietary polyphenol research: beyond drug discovery
Jin, T. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.179 · Cited by 43
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
Agrawal, A., Parlee, S. D., Pérez–Tilve, D., Li, P., Pan, J. H., Mroz, P. A., Hansen, A. M. K., Andersen, B., Finan, B., Kharitonenkov, A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.003 · Cited by 42
Self-citationTorre-Villalvazo, I., Alemán, G., Valle‐Rios, R., & Noriega, L. G. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.06.006 · Cited by 45
Figarska, S. M., Rigdon, J., Ganna, A., Elmståhl, S., Lind, L., Gardner, C. D., & Ingelsson, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-64636-7 · Cited by 41
Lee, H., Lee, T. J., Galloway, C. A., Zhi, W., Xiao, W. L., Bentley, K. L. D. M., Sharma, A. K., Teng, Y., Sesaki, H., & Yoon, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-42564-0 · Cited by 45
FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity
Ye, M., Lu, W., Wang, X., Wang, C., Abbruzzese, J. L., Liang, G., Li, X., & Luo, Y. (2016) · Endocrinology · doi:10.1210/en.2016-1710 · Cited by 41
Domouzoglou, E. M., Fisher, F. M., Astapova, I. I., Fox, E. C., Kharitonenkov, A., Flier, J. S., Hollenberg, A. N., & Maratos–Flier, E. (2014) · Endocrinology · doi:10.1210/en.2013-1902 · Cited by 41
Self-citationXu, Q., Zhang, J., Lu, Y., & Wu, L. Y. (2024) · iScience · doi:10.1016/j.isci.2024.108783 · Cited by 43
Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression
Girer, N. G., Murray, I. A., Omiecinski, C. J., & Perdew, G. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.715151 · Cited by 40
Krout, D., Roemmich, J. N., Bundy, A. N., Garcia, R. A. G., Yan, L., & Larson, K. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.013 · Cited by 42
Goto, T. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1559025 · Cited by 39
Bartesaghi, S., Wallenius, K., Hovdal, D., Liljeblad, M., Wallin, S., Dekker, N., Barlind, L., Davies, N. M., Seeliger, F., Winzell, M. S., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.010 · Cited by 40
Novotný, D., Vaverková, H., Karásek, D., Lukeš, J., Slavík, L., Malina, P., & Orság, J. (2014) · Physiological Research · doi:10.33549/physiolres.932602 · Cited by 39
Claflin, K. E., Sullivan, A. I., Naber, M. C., Flippo, K. H., Morgan, D. A., Neff, T. J., Jensen-Cody, S. O., Zhu, Z., Zingman, L. V., Rahmouni, K., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101564 · Cited by 37
Patel, S., Haider, A., Álvarez-Guaita, A., Bidault, G., Moustafa, J. S. E.-S., Guiu‐Jurado, E., Tadross, J. A., Warner, J., Harrison, J., Virtue, S., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101589 · Cited by 42
Uebanso, T., Taketani, Y., Yamamoto, H., Amo, K., Tanaka, S., Arai, H., Takei, Y., Masuda, M., Yamanaka‐Okumura, H., & Takeda, E. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.023 · Cited by 39
Gilardi, F., Giudici, M., Mitro, N., Maschi, O., Guerrini, U., Rando, G., Maggi, A. C., Cermenati, G., Laghezza, A., Loiodice, F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506394 · Cited by 39
Hollstein, T., Ando, T., Basolo, A., Krakoff, J. A., Votruba, S. B., & Piaggi, P. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz062 · Cited by 38
Liver Brain Interactions: Focus on FGF21 a Systematic Review
Prida, E., Álvarez-Delgado, S., Pérez-Lois, R., Soto-Tielas, M., Estany‐Gestal, A., Fernø, J., Seoane, L. M., Quiñones, M., & Al–Massadi, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113318 · Cited by 40
Camacho, R. C., Zafian, P., Achanfuo-Yeboah, J., Manibusan, A., & Berger, J. P. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.023 · Cited by 38
Lee, D. V., Li, D., Yan, Q., Zhu, Y., Goodwin, B. J., Calle, R. A., Brenner, M. B., & Talukdar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111767 · Cited by 38
Libby, A. E., Bales, E. S., Monks, J., Orlicky, D. J., & McManaman, J. L. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m086249 · Cited by 38
Zhang, J., Wu, H., MA, S., Jing, F., Yu, C., Gao, L., & Zhao, J. (2018) · Physiological Research · doi:10.33549/physiolres.933650 · Cited by 38
Chalvon-Demersay, T., Even, P. C., Tomé, D., Chaumontet, C., Piedcoq, J., Gaudichon, C., & Azzout-Marniche, D. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.07.002 · Cited by 37
Fibroblast growth factor 21 in metabolic syndrome
Yang, M., Liu, C., Jiang, N., Liu, Y., Luo, S., Li, C., Zhao, H., Han, Y., Chen, W., Li, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1220426 · Cited by 40
Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis
Guo, X., Asthana, P., Zhai, L., Cheng, K. W., Gurung, S., Huang, J., Wu, J., Zhang, Y., Mahato, A. K., Saarma, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45452-3 · Cited by 44
Ma, R., Shi, G.-Y., Li, Y., & Shi, H. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524000631 · Cited by 37
Khan, F. H., Shaw, L., Zhang, W., Gonzalez, R. M. S., Mowery, S., Oehrle, M., Zhao, X., Jenkins, T. M., Setchell, K. D. R., Inge, T. H., et al. (2016) · Obesity · doi:10.1002/oby.21658 · Cited by 37
Izaguirre, M., Gil, M. J., Monreal, I., Montecucco, F., Frühbeck, G., & Catalán, V. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0866-3 · Cited by 41
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 37
Morita, M., Siddiqui, N., Katsumura, S., Rouya, C., Larsson, O. S., Nagashima, T., Hekmatnejad, B., Takahashi, A., Kiyonari, H., Zang, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816023116 · Cited by 37
Kim, C.-S., Joe, Y., Choi, H., Back, S. H., Park, J. W., Chung, H., Roh, E., Kim, M., Ha, T. Y., & Yu, R. (2019) · Journal of Inflammation · doi:10.1186/s12950-019-0221-3 · Cited by 36
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
Gallego‐Durán, R., Ampuero, J., Maya‐Miles, D., Pastor‐Ramírez, H., Montero‐Vallejo, R., Rivera‐Esteban, J., Álvarez‐Amor, L., Pareja, M. J., Rico, M. C., Millán, R., et al. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12534 · Cited by 35
Johnson, C. L., Mehmood, R., Laing, S. W., Stepniak, C. V., Kharitonenkov, A., & Pin, C. L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00559.2013 · Cited by 36
Self-citationTranscriptional Regulation of Fibroblast Growth Factor 21 Expression
Bae, K.-H., Kim, J., & Park, K. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.2.105 · Cited by 37
A High Phosphorus Diet Affects Lipid Metabolism in Rat Liver: A DNA Microarray Analysis
Chun, S., Bamba, T., Suyama, T., Ishijima, T., Fukusaki, E., Abe, K., & Nakai, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155386 · Cited by 38
Tamucci, K. A., Namwanje, M., Fan, L., & Qiang, L. (2017) · Protein & Cell · doi:10.1007/s13238-017-0434-2 · Cited by 39
FGF-21 Elevated IL-10 Production to Correct LPS-Induced Inflammation
Li, J., Wang, N., Khoso, M. H., Shen, C.-B., Guo, M.-Z., Pang, X.-X., Li, D., & Wang, W. (2018) · Inflammation · doi:10.1007/s10753-018-0729-3 · Cited by 36
Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease
Shen, Y., Zhang, X., Xu, Y., Xiong, Q., Lu, Z., Ma, X., Bao, Y., & Jia, W. (2018) · Cardiology · doi:10.1159/000486127 · Cited by 36
Emerging Structure–Function Paradigm of Endocrine FGFs in Metabolic Diseases
Luo, Y., Ye, S., Li, X., & Lu, W. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.002 · Cited by 37
Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Taliyan, R., Chandran, S. K., & Kakoty, V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716101411 · Cited by 35
Li, S., Wang, W., Zhou, L., Ma, L., An, Y., Xu, W.-J., Li, T.-H., Yu, Y.-H., Li, D., & Liú, Y. (2014) · Endocrine · doi:10.1007/s12020-014-0309-8 · Cited by 36
Leptin as a Potential Regulator of FGF21
Asrih, M., Veyrat‐Durebex, C., Poher, A.-L., Lyautey, J., Rohner‐Jeanrenaud, F., & Jornayvaz, F. R. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443070 · Cited by 35
The Nuclear Receptor Rev-erbα Regulates Adipose Tissue-specific FGF21 Signaling
Jager, J., Wang, F., Fang, B., Lim, H., Peed, L. C., Steger, D. J., Won, K., Kharitonenkov, A., Adams, A. C., & Lazar, M. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719120 · Cited by 35
Self-citationChiba, A., Watanabe‐Takano, H., Miyazaki, T., & Mochizuki, N. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2723-6 · Cited by 37
Dietary protein dilution limits dyslipidemia in obesity through FGF21-driven fatty acid clearance
Maida, A., Zota, A., Vegiopoulos, A., Appak‐Baskoy, S., Augustin, H. G., Heikenwälder, M. F., Herzig, S., & Rose, A. J. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.027 · Cited by 34
The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis
Antonellis, P. J., Droz, B. A., Cosgrove, R., O’Farrell, L. S., Coşkun, T., Perfield, J. W., Bauer, S. M., Wade, M. R., Chouinard, T. E., Brozinick, J. T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.006 · Cited by 37
Hong, E. S., Lim, C., Choi, H. Y., Lee, Y. K., Ku, E. J., Moon, J. H., Park, K. S., Jang, H. C., & Choi, S. H. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000776 · Cited by 35
Queen, N. J., Bates, R., Huang, W., Xiao, R., Appana, B., & Cao, L. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.12.011 · Cited by 38
Low Protein Diets and Energy Balance: Mechanisms of Action on Energy Intake and Expenditure
Pezeshki, A., & Chelikani, P. K. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.655833 · Cited by 36
Promising therapies for treatment of nonalcoholic steatohepatitis
Noureddin, M., Zhang, A., & Loomba, R. S. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1220533 · Cited by 35
Worsch, S., Heikenwalder, M., Hauner, H., & Bader, B. L. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0291-x · Cited by 34
Glucagon receptor signaling regulates weight loss via central KLB receptor complexes
Nason, S. R., Antipenko, J., Presedo, N., Cunningham, S. E., Pierre, T. H., Kim, T., Paul, J. R., Holleman, C., Young, M. E., Gamble, K. L., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.141323 · Cited by 34
Self-citationPharmacotherapy for Nonalcoholic Fatty Liver Disease
Gawrieh, S., & Chalasani, N. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562951 · Cited by 35
Ramanjaneya, M., Bensila, M., Bettahi, I., Jerobin, J., Samra, T. A., Aye, M. M., Alkasem, M., Siveen, K. S., Sathyapalan, T., Skarulis, M. C., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.568500 · Cited by 34
Recently Discovered Adipokines and Cardio-Metabolic Comorbidities in Childhood Obesity
Barraco, G. M., Luciano, R., Semeraro, M., Prieto-Hontoria, P. L., & Manco, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119760 · Cited by 33
Akyol, M., Alacacıoğlu, A., Demir, L., Küçükzeybek, Y., Yıldız, Y., Gumus, Z., Kara, M., Salman, T., Varol, U., Taşkaynatan, H., et al. (2017) · Cancer Biomarkers · doi:10.3233/cbm-161507 · Cited by 34
Modulation of energy balance by fibroblast growth factor 21
Ramos, D. C., & Aguilar-Salinas, C. A. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0023 · Cited by 36
Rosenstock, M., Tseng, L., Pierce, A. A., Offman, E., Chen, C.-Y., Charlton, R., Margalit, M., & Mansbach, H. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001618 · Cited by 31
Influence of intermittent fasting on autophagy in the liver
Ma, Y., Jiang, X., Tang, W., & Song, P. (2023) · BioScience Trends · doi:10.5582/bst.2023.01207 · Cited by 36
Metadata
- Authors
- Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A.
- Affiliations
- Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285
- Eli Lilly (United States) (US)
- Corresponding author
- Kharitonenkov, Alexei
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2008-08-07
- Volume
- 149
- Issue
- 12
- Pages
- 6018-6027
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2114650931
- Cited by
- 1,031
- References
- 26
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 58 · 2023: 63 · 2022: 57 · 2021: 72 · 2020: 67 · 2019: 76 · 2018: 72 · 2017: 64 · 2016: 78 · 2015: 85 · 2014: 71 · 2013: 62 · 2012: 61
- FWCI
- 12.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- FGF21, obesity, diet-induced obesity, ob/ob mice, energy expenditure, fat oxidation, de novo lipogenesis, hepatic steatosis, insulin resistance, leptin resistance, glycemia, lipid excretion, adipose tissue, metabolic therapy
- MeSH terms
- Animals, Body Weight, Energy Intake, Dietary Fats, Energy Metabolism, Fibroblast Growth Factors, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Motor Activity, Obesity, Leptin, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
